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HyperglycemiaBackground and objective: Hyperglycemia leads to adaptive cell responses in part due to hyperosmolarity. In en-
dothelial and epithelial cells, hyperosmolarity induces aquaporin-1 (AQP1) which plays a role in cytoskeletal re-
modeling, cell proliferation and migration. Whether such impairments also occur in human induced pluripotent
stem cells (iPS) is not known.We therefore investigatedwhether high glucose-induced hyperosmolarity impacts
proliferation, migration, expression of pluripotency markers and actin skeleton remodeling in iPS cells in an
AQP1-dependent manner. Methods and results: Human iPS cells were generated from skin fibroblasts by
lentiviral transduction of four reprogramming factors (Oct4, Sox2, Klf4, c-Myc). After reprogramming, iPS cells
were characterized by their adaptive responses to high glucose-induced hyperosmolarity by incubation with
5.5 mmol/L glucose, high glucose (HG) at 30.5 mM, or with the hyperosmolar control mannitol (HM). Exposure
to either HG or HM increased the expression of AQP1. AQP1 co-immunoprecipitatedwith β-catenin. HG and HM
induced the expression of β-catenin. Under these conditions, iPS cells showed increased ratios of F-actin to G-
actin and formed increased tubing networks. Inhibition of AQP1 with small interfering RNA (siRNA) reverted
the inducing effects of HG and HM. Conclusions: High glucose enhances human iPS cell proliferation and cyto-
skeletal remodeling due to hyperosmolarity-induced upregulation of AQP1.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Transplantation of stem cells is emerging as a promising strategy for
the repair and regeneration of damaged organs or tissues, including
those in the cardiovascular system [1]. However, major limitations re-
main for the use of adult stem cells harvested from essential organs, in-
cluding the paucity, immunogenicity and low potency of adult stem
cells. Advances in stem cell biology have recently offered new opportu-
nities for regenerative therapies, enabling the generation of induced
pluripotent stem (iPS) cells [2,3] or even induced cardiomyocytes [4]
from somatic cells of readily obtainable human tissue source. However
an issue has been raised on a potentially lower yield of iPS cells obtained
from patients in need of them, because disease or agingmay render the
reprogramming process of iPS cells from somatic cells less efficient, par-
ticularly when the original stem cell preparation is of poor quality [5–9].'Annunzio” University— Chieti,
ti, Italy. Tel.: +39 0871 41512;It is therefore of importance to determine whether and to what extent
pathophysiological conditions, such as those occurring in diabetes, im-
pair iPS cells, or create a microenvironment harmful or hostile for the
subsequent iPS cell implantation. Recent studies have indeed docu-
mented that biophysical factors, including hyperosmolarity, as occur-
ring in diabetic hyperglycemia, may represent important regulatory
elements influencing stem cell fate, both in physiological and patholog-
ical conditions [10–13]. In the diabetic setting, hyperglycemia has been
indeed shown to be involved in the control of stem and progenitor cell
fate and cell reprogramming [14–18].
In addition to being a macronutrient and a metabolic regulator,
glucose is an osmotically active molecule. While the effects of
hyperosmolarity have been extensively studied in adult cultured cells,
demonstrating changes in cell shape, nutrient transport, proliferation
and growth [19–23], nothing is known on its effects on the properties
and fate of iPS cells in in vitro conditions mimicking diabetes.
Against this background, we therefore hypothesized that disease-
related changes may affect the somatic reprogramming of iPS cells. Con-
sequently, we aimed at specifically investigating the cellular response of
iPS cells to high glucose-induced hyperosmolarity, pursuing an analysis
2267R. Madonna et al. / Biochimica et Biophysica Acta 1842 (2014) 2266–2275of iPS cell growth, migration, actin skeleton remodeling and expres-
sion of pluripotency markers in response to one biophysical condi-
tion — increased osmolarity — mimicking that occurring in diabetic
hyperglycemia.
2. Materials and methods
2.1. Reagents
D-Glucose, D-mannitol (devoid of metabolic activities and used as a
purely hyperosmolar control), and all other chemicals were purchased
from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise specified.
2.2. iPS cell generation
Human foreskin fibroblasts [purchased from American Type Culture
Collection (ATCC, Manassas, VA, USA)] were used to establish human
iPS cells. Lentiviral vectors expressing 4 reprogramming transcription
factors— octamer-binding transcription factor (OCT)-4, sex determining
region Y (SRY)-box 2 (SOX2), Kruppel-like factor (KLF)-4, and c-MYC—
and green fluorescence protein (GFP) as a reporter gene under the con-
trol of the human elongation factor-1 alpha promoter (EF1μ) were pur-
chased from Open Biosystems (ThermoFisher Scientific, Huntsville, AL,
USA). Fibroblasts were seeded at 1.5 × 104 cells/cm2 in 24-well plates
in Eagle's Minimum Essential Medium (MEM) supplemented with 10%
fetal bovine serum (FBS). At 30–40% confluence, cells were transduced
with equal amounts of particles (at multiplicity of infection (MOI) of
1:10) of the lentiviral vectors encoding the four transcription factors (av-
erage titer: 5 × 108 transducing units (TU)/mL), for a total MOI of 40 de-
livered to target cells. Cells were thenmaintained in embryonic stem cell
(ES)-specific medium (from Stem Cell Biotechnology, Vancouver,
Canada). Following 2 to 3 weeks of culture in enriched natural seawateriPS cells pre-incubated with
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Fig. 1. Experimental protocol of high glucose-induced hyperosmolarity in induced pluripotent s
siRNA, silencing RNA; AQP, aquaporin; DMEM, Dulbecco's Modified Eagle Medium; FCS, fetal c(ES)medium, compact ES-like colonies emerged among a background of
fibroblasts, and colonies with ES cell morphology were manually picked
and transferred to new dishes for further experiments (online Supple-
ment Fig. 1). The iPS cell lines were confirmed by teratoma formation
assay and for the positivity of OCT-4, SOX2, KLF-4 and Nanog by immu-
noblotting. More than three reprogramming experiments were per-
formed and at least three clones for each experiment were analyzed.
The iPS cells were stored in liquid nitrogen until further experiments.2.3. Experimental design
Human iPS cells were characterized for their adaptive responses to
high glucose- and high mannitol-induced hyperosmolarity for up to
24 h (Fig. 1). After thawing, the iPS cells were let to recover by plating
them in ES-specific medium. After reaching 70% confluency, cells were
synchronized to be in the same cell-cycle phase by starvation in low-
glucose (5.5mM)Dulbecco'sModified EagleMedium (DMEM) contain-
ing 2% fetal calf serum (FCS) for 24 h. After synchronization, iPS cells
were separated into 5 groups and incubated with control glucose con-
centration (5.5 mM, control), high glucose (HG, 30.5 mM, respectively),
or high mannitol (HM, 5.5 mM glucose + 25mMmannitol, respective-
ly) up to 24 h in separate experiments, respectively (Fig. 1). After os-
motic stress conditions, cells from all the 3 groups were collected for
in vitro assays as follows. Cell size, water permeability and cell prolifer-
ation were monitored at different time points (0–15–30–60 s, 15 min,
and 1 and 24 h), while protein expression of different targets (KLF-4,
SOX-2, Nanog, OCT, GAPDH, G-actin, F-actin, AQP1, β-catenin) as well
as flow-cytometry analyses of AQP1 expression (online Supplement
Figs. 2 and 3), migration assays in Matrigel and visualization of the F-
actin cytoskeleton were assessed after 24 h. In some preliminary exper-
iments, cell volume was also measured at different osmotic environ-
ments (HG at 17.5, 50.5, 105.5 and 185.5 mM and corresponding HMe-induced
olarity
itol-induced
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tained in OptiMem reduced serum medium (Invitrogen) to avoid the
cell detachment and death due to starvation. Basal DMEM or OptiMem
media have an inorganic salt concentration of 120 mM, a glucose (or
mannitol) concentration of 5.5 mM, and an osmolality in the range of
322–374 mOsm/kg of H2O. After osmotic stress and control conditions,
cell viability was assessed by cell morphology and cell count using
phase-contrastmicroscopy, Trypan blue exclusion and total protein con-
tent. Cell proliferation was assessed by determining the GFP-positive
cells using a POLARstar OPTIMA plate reader (BMG Labtechnologies,
Offenburg, Germany). Green fluorescence emission with an emission
peak of 523 nm was detected. Cell size was assessed using a Multisizer
™ 3 Coulter counter equipped with a Channelyzer (Beckman Coulter,
Miami, FL, USA). The number of GFP-positive cells was assessed using a
FACSCalibur flow cytometer (BD Biosciences, CA, USA).
2.4. Fluorescence-activated cell sorting (FACS) analysis of reprogrammed
cells
Dissociated ES-like colonies were plated in serum-starved in low glu-
cose DMEM containing 2% FCS for 24 h, and then incubated with control
glucose (5.5mM, control), high glucose (HG, 30.5mM), or highmannitol
(HM, 5.5mMglucose+25mMmannitol) for 24 h. To quantify the num-
ber of GFP-positive cells and AQP1-positive cells, after incubation, iPS
cells were incubated with the AQP1 primary antibody (Santa Cruz)
followed by secondary antibody (anti-mouse IgG + the PerCP–CY5
fluorophore), then sorted using FACS (FACSCalibur flow cytometer,
Becton Dickinson, BD). See online Supplement for further details.
2.5. Transfection of AQP1 siRNA
A pool of three different small interfering RNA (siRNA) oligonucleo-
tides against AQP1 conjugated with cyan (Cy)-5 or scrambled control
siRNAs were obtained from Ambion (Invitrogen). Cells (2 × 105/well)
were plated on 6-well plates in low-serummediumwithout antibiotics
(OptiMem) and incubated with 6 μL of siRNA transfection reagent
mixed with siRNAs (60 μmol/L) up to a total volume of 800 μL transfec-
tion medium. After 24 h, a fresh medium was added with or without
glucose or mannitol (5.5 or 30.5 mM) and incubated for an additional
24 h; cells were then harvested using ethylenediaminetetraacetic acid
(EDTA)/phosphate buffered saline (PBS) without trypsin, and proteins
were extracted for further experiments.
2.6. Migration assays
Migration assays were performed with Matrigel in 96-well plates
(BD Biosciences, San Jose, CA, USA), allowing the formation of both
tubules and a vascular-like network. Before the assay, human control fi-
broblasts or human iPS cells were grown for 24 h in endothelial basal
medium (EBM, BD Biosciences) without endothelial growth factors,
supplemented with 2.5% FBS and control concentrations of glucose
(5.5 mM, control), and then shifted to the same medium with either
control glucose (5.5mM, control), high glucose (30.5mM) or highman-
nitol (5.5 mM glucose + 25mMmannitol, or with siRNA to AQP1) and
plated on Matrigel (at a density of 2 × 105 cells/50 μL of Matrigel) for
further 24 h. Images were acquired in Normaski mode with red and
green channels using a 10× objective on an immunofluorescence mi-
croscope (Leica, Wetzlar, Germany), and pictures were taken by an at-
tached digital output Olympus camera. Several tube formation indices
(tube areas, tube length, and tube number) were quantified using the
National Institutes of Health (NIH) Image software (version 1.62).
2.7. Immunoprecipitation and immunoblotting
Total proteins were isolated in ice-cold radioimmunoprecipitation
(RIPA) buffer [24]. Proteins were separated under reducingconditions and electroblotted onto polyvinylidene fluoride mem-
branes (Immobilon-P; Millipore, Bedford, MA, USA). After blocking,
the membranes were incubated overnight at 4 °C with the following
primary antibodies: (1) AQP1 (Santa Cruz), (2) β-actin (Sigma),
(3) β-catenin (Cell Signaling, Billerica, MA, USA), (4) KLF-4 (Cell Signal-
ing), (5) Sox-2 (Cell Signaling), (6) Nanog (Cell Signaling), and (7) OCT-
4 (Cell Signaling). Equal loading/equal protein transfers were verified
by stripping and re-probing each blot with an anti-GAPDH antibody.
For immunoprecipitation, cell lysates were mixed with the monoclonal
mouse anti-AQP1 antibody and the immunocomplexes were pulled
down with protein-A/G beads (Santa Cruz). The immunoprecipitants
were then eluted, concentrated and subjected to immunoblotting for
AQP or β-catenin.2.8. Fluorescence-quenching assay
A fluorescence quenching assaywas performed according to a previ-
ously published protocol [25]. Here, iPS cells were seeded on black,
clear-bottomed plates (Corning), grown for 2 days at 37 °C, 5% CO2
and 95% relative humidity, and loadedwith calcein-AMester (BD Biosci-
ences). Before loading the cells with the calcein-AM ester in assay buffer
(0.8mMMgSO4, 5mMKCl, 1.8mMCaCl2, 25mMNa-HEPES, pH adjust-
ed to 7.4 with HCl), the growth medium was exchanged with the fresh
medium for 1 h. All assay plates were washed with a fresh assay buffer,
and then treated with the osmolytes (glucose or mannitol) ranging in
concentrations between 5.5 and 30.5 mM. Calcein fluorescence was re-
corded on a Fluostar Optima plate reader (BMG LABTECH, Ortenberg,
Germany) equipped with a 495-nm band-pass filter for excitation and
a 520-nm long-pass filter for emission. Osmotic gradients were applied
5 s after the beginning of each baseline reading through the instrument.
Dynamic changes in fluorescence intensity were recorded for an addi-
tional 15, 30 and 60 s, 15 min, 1 and 24 h.2.9. Visualization of the F-actin cytoskeleton
F-actin incorporated into the cytoskeleton was visualized in iPS cells
grown on cover slips, after permeabilization and incubation with
phalloidin (rhodamine). iPS cells were grown on cover slips at a density
of 30,000 cells per cover slip. After stimulation with an isotonic solution
(105 mM NaCl, 6 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM HEPES,
5.5 mM glucose, adjusted to pH 7.4 with NaOH) or a hypertonic solution
(105 mM NaCl, 6 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM HEPES,
30.5 mM glucose or 5.5 mM glucose/25 mM mannitol, adjusted to
pH 7.4 with NaOH) for 24 h, cells were fixed in 3.7% fresh formaldehyde
for 15 min at room temperature, washed twice, and permeabilized in
0.2% Triton X-100. After permeabilization, cells were incubated in
14 μMphalloidin (rhodamine) (Acti-stain 535, 1:100 dilution, purchased
fromCytoskeleton Inc, Denver, CO, USA) for 40min at room temperature.
Stained samples were treated with Vectashield/DAPI mounting medium
for fluorescence to retard photobleaching. All incubation and washing
steps were performed in TRIS-buffer (TBS, 10 mM Tris–HCl, pH 7.3,
150 mM NaCl, 1 mMMgCl2 and 1 mM EGTA) at room temperature.2.10. Measurement of monomeric and polymeric F- and G-actin
Quantitation of the ratio of F-actin incorporated into the cytoskeleton
to G-actin found in the cytosol was performed using a G-actin/F-actin
assay kit (Cytoskeleton Inc, Denver, CO, USA) according to the
manufacturer's instructions. In brief, iPS cells were homogenized in an
F-actin stabilization buffer, and then centrifuged to separate the F-actin
from the G-actin pool. The fractions were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and actin was
quantified using Western blotting.
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Two-group comparisons were performed using the Student's t-test
for unpaired values. Multiple-group comparisons were made using
analysis of variance (ANOVA), and the existence of individual differ-
ences, in case of significant F-values at ANOVA, tested by Scheffé's mul-
tiple contrasts. A P-value of less than 0.05 was considered significant.
3. Results
3.1. High glucose-induced hyperosmolarity impacts cell size and water
permeability of human induced pluripotent stem cells
We tested the effect of hyperosmolarity on iPS cell size by incubating
iPS cells with high glucose (HG) and high mannitol (HM), the latter de-
void of glucose metabolic effects but increasing extracellular osmolarity
to the same extent as high glucose. Cell size (as measured by diameter)
changes in iPS cells in response to changes in extracellular osmolarity
were assessed in suspended cells using a Coulter counter. Cell size mea-
surements as shown in Fig. 2A were recorded at different time points
(0–15–30–60 s, at 15 min, at 1 and 24 h) after exposure to aF t
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Fig. 2. Time-course of changes in cell size and water permeability in human induced plu-
ripotent stem cells exposed to high glucose-induced hyperosmolar stress: iPS cells were
detached by gentle trypsin/EDTA treatment and resuspended in iso-osmotic buffer.
Starting at iso-osmotic glucose concentration (5.5 mM) and up to 30.5 mM, a series of
rapid osmotic shifts was conducted for 0–15–30–60 s, at 15 min, at 1 and 24 h. Changes
in (A) cell size measurements (with a Multisizer™ 3 Coulter counter) in 3 replicate
wells and (B) in average fluorescence intensity (described as the ratio Ft/F0 of fluores-
cence F at time t to initial fluorescence F0) over time in 8 replicate wells before and after
application of the indicated osmotic sugar concentration, are shown. Cell size and water
permeability responses to altered extracellular osmolarity respectively follow positive
and negative curvilinear trends, where the size decreases during exposure times after
60 s. while the water permeability returns to baseline. Each indicator reflects the mean
cell size (cell diameter expressed in μm) (A) or the mean ratio Ft/F0 (B) of 10,000 cells
in an individual measurement. Data are from 3 independent experiments. **, p b 0.01 vs
non-stimulated iPS cells; *, p b 0.05 vs non-stimulated iPS cells.hyperosmolar medium by the addition of HG or HM (30.5 mM), and 60
s after a shift in extracellular osmolarity from iso-osmotic concentrations
(5.5mM) to a range of concentrationwith higher osmolarities (from12.5
to 185.5 mM) (online Supplement Fig. 4A and B). Increasing osmolarity
with HG or HM up to 30.5 mmol/L for 60 s caused a significant increase
in cell size, while further increases in osmolarity decreased cell size (on-
line Supplement Fig. 4A and B). No significant changes in cell size were
recorded after 15 s and 30 s loading HG (30.5 mM glucose) or HM
(5.5mMglucose+25mMmannitol), while stable cell shrinkingwas ob-
served after 15 min, 1 and 24 h (Fig. 2A).
To further analyze the effects of hyperosmolarity on iPS cells in
terms of water permeability, we implemented a functional assay
based upon calcein fluorescence quenching, a well-established method
for the measurement of rapid osmosis in monolayers of cultured cells
[26]. Cultured cells in the 96-well format were loaded with calcein-
AM, a membrane-permeable calcein derivative that is cleaved intracel-
lularly by esterases to become trapped in the cytoplasm. The functional
assay of iPS cells was performed in a fluorimetric plate reader as de-
scribed in the Materials and methods section. Cells were rinsed in
50 μL of isosmolar PBS. The extent of fluorescence change (expression
of themovement of calcein from inside to outside of the cell through os-
motic gradients) was determined using the ratio between fluorescence
before (Ft) and after (F0) a change in the extracellular osmolyte (glucose
or mannitol) concentrations (Fig. 2B). Cell volume and permeability
changes in response to osmotic gradients can be rapid if facilitators of
water permeability, such as AQP1, are present [27]. Following very
short incubations (15, 30 and 60 s), calcein quenching in response to
osmolytes became clearly visible. After 60 s, fluorescence intensity ap-
peared to be at equilibrium, and we did not observe any further fluores-
cence intensity changes up to 15 min that could indicate changes in
cellular osmolyte permeability (Fig. 2B). We tested the response of iPS
cells to the addition of osmotic shifts from isosmotic (5.5 mM) to a final
extracellular osmolarity of 30.5 mM.We observed significant differences
after loading HG (30.5 mM glucose) or HM (5.5 mM glucose + 25 mM
mannitol) for 30 s (p b 0.01) and 60 s (p b 0.05) (Fig. 2B). Thus, iPS
cells appear osmotically sensitive because they are able to sense
and respond to hyperosmolarity by changing their size and water
permeability.
3.2. High glucose but not high mannitol drives the expression of
pluripotency markers in human induced pluripotent stem cells
To investigate whether environmental cues such as high glucose-
induced hyperosmolarity impact the expression of pluripotency
markers of iPS cells, we determined the differences in expression of
KLF-4, Sox-2, Nanog and OCT-4 among experimental conditions tested
(Fig. 3). Twenty-four hour exposure to HG (30.5 mM) — but not HM
(5.5 mM glucose + 25 mM mannitol) — changed protein expression
of KLF-4 with a 2.8-fold increase, with 1.5 increase of OCT-4, and a
near-doubling of Nanog and SOX-2, as determined byWestern analysis
(Fig. 3). Thus, hyperosmolarity per se does not appear to impact
markers of the pluripotency potential of iPS cells. In parallel experi-
ments, cells were also incubated with sodium chloride and saccharose
at equimolar concentrations, as further osmotic control, and similar re-
sults were obtained.
3.3. High glucose induces cell proliferation of human induced pluripotent
stem cells through a hyperosmolar mechanism
To evaluate whether increased levels of pluripotencymarkers trans-
late into increased cell proliferation, differences in cell numbers be-
tween the different conditions were determined. Data reported in
Fig. 4 were obtained by analyzing the expression of the green fluores-
cence protein (GFP) reporter gene in iPS cells after 1 h and 24 h expo-
sures to a hyperosmolar medium by the addition of glucose or
mannitol (30.5 mM). As shown in Fig. 4A and B, the rate of cell
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bation with HG and HM than in those cultured with normal glucose
(5.5 mM). Similarly, no significant changes in cell proliferation were re-
corded after 15–30–60 s and 15 min of incubation with HG and HMC
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formation of osmopodia
Under isotonic conditions (5.5 mM glucose), iPS cells appeared
rounded and organized in compact ES-like colonies, with visible stress
fibers (stained in red) running through the cytosol (Fig. 5A). However,
their morphology and spatial organization changedmarkedly when ex-
posed to a hyperosmolar medium. In HG or HM, the initial cellular re-
sponse was a decreased cell volume. Cells shrank rapidly (with the
shrinking process being completed in a few second). The cells then
started extending cytoplasmic protrusions termed osmopodia [28].
The osmopodia extension process started after 10 min in medium at
30.5 mM of osmolyte concentration (physiological osmolality is
286 mOsm, which is produced by 5.5 mM glucose concentration).
Fig. 5 shows osmopodia formation from iPS cells at 30.5 mM
hyperosmolarity. Podia extension was rare in an isotonic mediumFE
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Fig. 5.Reorganization of F-actin and formationof osmopodia inhuman inducedpluripotent stemc
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In panel O, merged fluorescence from the GFP and F-actin in iPS cells incubated with HM. Scale b(panel A). However, as the osmolarity of medium increased (panels
A–D), the frequency and length of the podia increased dramatically,
documenting the induction of the osmopodia by hyperosmolarity. The
length and number of osmopodia per cell and the dynamics of
osmopodia extension were variable even in a homogeneous iPS cell
population. Some cells began osmopodia extension as soon as they
completed the shrinking process, while others responded slowly to os-
motic stress, causing a diverse distribution of osmopodia lengths. The
number of osmopodia extending to a noticeable size per cell ranged
from one to five. Based on cellular volume change as an initial cellular
response to the abrupt osmolarity shift, we investigated osmotically ac-
tivated ion and water transport mechanisms across the cellular mem-
brane. During preliminary experiments observing morphological
changes in cells in a drop of cell suspension on a glass slide, we found
that fluorescently labeled cells (GFP-positive iPS cells), particularly
those located near the edge of the drop, showed a significant increaseC D GFPF-Actin
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ells exposed to highglucose-inducedhyperosmolar stress. iPS cellswere incubated for 24h in
5 mMmannitol + 5.5 mM glucose (I–O)]. F-actin was stained with rhodamine-conjugated
ng of nuclei; in green, iPS cells expressing green fluorescent protein (GFP) as a reporter gene.
in I and L indicateGFP-positive iPS cellswith F-actin staining in the samefield as panelsM–N.
ar: 10 μm.
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hyperosmolarity-induced osmopodia extension.
The actin skeleton is known to play a crucial role in cell protrusion and
changes in cell volume and shape [29]. It was therefore conceivable that
hyperosmolarity exerts its effect on osmopodia formation through a per-
turbation of the actin skeleton. To assess the effect of hyperosmolarity on
the actin skeleton, iPS cells and osmopodia in either an isotonic of a
hyperosmolar medium were stained in situ after fixation with
rhodamine-conjugated phalloidin, which specifically visualizes the poly-
meric (F) actin. Indeed, when cells were stained with rhodamine-
conjugated phalloidin, F-actinwas also detected on the osmopodia. How-
ever, even though all iPS cell populations tested here showed a strong
positivity in staining for the GFP-reporter gene, this green fluorescent
protein (which localizes in the nuclei as well as in the cytoplasm) was
not detected in the osmopodia (Fig. 5E and F). In Fig. 5, the rhodamine/
phalloidin-stained iPS cells showed osmopodia extended at 30.5 mM os-
molarity (Fig. 5B, C andG). Interestingly, the podia anchored to other cells
or to the surface of the culture plate, forming structures similar to
tenupodia (arrows in Fig. 5I) [28]. Tenupodia are thin, linear segments
that bifurcatemultiple times [28], and are suggested to play both sensory
and mechanical roles during migration and homing of hematopoietic
stem cells [28].3.5. Hyperosmolarity-induced skeleton remodeling is associated with de
novo F-actin assembly in iPS cells
We assessed whether the effect of hyperosmolarity on the actin
skeleton is associated with the de novo assembly of F-actin. Changes
in F-actin versus G-actin were quantified by Western blotting using a
G-actin/F-actin assay (as reported in Materials and methods section)
(Fig. 6). In iPS cells exposed to HG (30.5 mM glucose) and HM
(5.5 mM glucose + 25mMmannitol), hyperosmolarity induced signif-
icant F-actin polymerization, as determined by a 2-fold increase in F-
actin (Fig. 6A).
The integrity of the F-actin cytoskeleton is critically dependent on
cell volume changes; several volume-regulated transport proteins,Glucose, mM
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Fig. 6. The effect of AQP1 on G/F actin redistribution in human induced pluripotent stem
were transfected with a pool of siRNAs to AQP1 or siRNAs to a scrambled sequence for 24
(HM, 5.5mMglucose+ 25mMmannitol). At the end of treatment, the G- versus F-actin conten
and methods section. Panel A shows increased expression of F-actin versus G-actin in iPS cells
actin redistribution. Representative immunoblots from 3 different experiments are shown. **,including water channels, exhibit functional interaction, with the cyto-
skeleton playing a pivotal role in cell volume regulation [30]. iPS cells
(see Fig. 7A, online Supplement Figs. 2 and 3) andfibroblasts before trans-
duction [31] express AQP1. To address themechanismunderlying the ob-
served F-actin polymerization in iPS cells exposed to hyperosmolarity, we
knocked down the AQP1 water channel using a pool of 3 different siRNA
oligonucleotides. A significant suppression of AQP1 (about 90%) occurred
in iPS cells transfected with siRNAs against AQP1. As a control for the
specificity of the siRNA approach, we determined the expression of
AQP1 after transfection with a scrambled sequence of siRNA serving
as a sequence-unrelated control. AQP1 expression was essentially
unchanged with the control reagents. Conversely, in iPS cells ex-
posed to hyperosmolarity (HG: 30.5 mM glucose and HM: 5.5 mM
glucose + 25 mM mannitol), the silencing of AQP1 prevented the de
novo assembly of F-actin induced by hyperosmolarity (Fig. 6B). Taken
together, these experiments suggest that hyperosmolarity promotes
de novo F-actin assembly, and that AQP1 is an important contributor
to the hyperosmolar F-actin response.3.6. AQP1 is expressed in iPS cells and affects their migration potential
Because AQP1 has been demonstrated to mediate the effects of
hyperosmolarity [32] and to be involved in cell migration [33], we inves-
tigated the effect of this water channel on cell migration in iPS cells. As
shown in Fig. 7A, B and D, 24 h exposure of iPS cells to a hyperosmolar
medium by the addition of glucose or mannitol (30.5 mM) increased
AQP1 expression at immunoprecipitation. We seeded iPS cells on
Matrigel after incubationwith high glucose or highmannitol in the pres-
ence or absence of AQP1 silencing. In this functional assay of cell migra-
tion, iPS cells formed bundles in methylcellulose matrix and tubing
networks in Matrigel, and high glucose or high mannitol produced the
highest number of network formations (Fig. 7E and F). AQP1 knock-
down drastically decreased network numbers and the area formed by
iPS cells seeded in Matrigel compared with glucose and mannitol-
treated cells, indicating a role for AQP1 in mediating hyperosmolarity-
induced iPS cell migration. In contrast, scrambled sequences of siRNAsiRNA-scr AQP1-siRNA
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Fig. 7.A–D and E–F. Co-immunoprecipitation of AQP1 and beta-catenin in human induced pluripotent stem cells exposed to high glucose-induced hyperosmolar stress (A–D). Human iPS
cells were incubatedwith control glucose (5.5 mmol/L, control), high glucose (HG, 30.5 mmol/L), or highmannitol (HM, 5.5mMglucose+ 25mMmannitol) for 24 h. At the end of treat-
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panel D. Tubulization of human induced pluripotent stem cells exposed to high-glucose induced hyperosmolar stress via AQP1 (E–F). The effect of AQP1 gene silencing on high
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cells were enzymatically harvested, plated onMatrigel-coated 96well-plates, and further incubatedwith stimuli for 24 h. After incubation, imageswere taken and analyzed as indicated in
Materials andmethods section. Tubule quantification (arbitrary units) from 3 different experiments is shown. *, p b 0.05 vs non-stimulated iPS cells treatedwith scrambled siRNA control;
**, p b 0.01 vs stimulated iPS cells treated with scrambled siRNA control.
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data indicate that hyperosmolarity influences the migration capacity of
iPS cells primarily through the activation of upstream mediators of
hyperosmolarity, such as AQP1.
3.7. Beta-catenin co-immunoprecipitates with AQP1 in iPS cells exposed to
hyperosmolarity
β-Catenin has been reported to promote actin reorganization and is
required for the organization of the cytoskeleton [34]. β-Catenin can re-
cruit cell adhesionmolecules, receptors, ion channels and signaling pro-
teins [35]. We therefore investigated the possible interaction between
the water channel AQP1 and β-catenin, and some of the downstream
signaling of AQP1 in iPS cells exposed to hyperosmolarity. We tested
this interaction byusing co-immunoprecipitation to determinewhether
β-catenin is a component of an AQP1-containing complex. When
confluent iPS cell lysates were immunoprecipitated with an AQP1-
antibody (but not with a pre-immune serum), β-catenin was co-
immunoprecipitated, thus suggesting that β-catenin interacts with
AQP1 (Fig. 7C and D). Twenty-four-hour exposure of iPS cells to a
hyperosmolar medium by the addition of glucose or mannitol (at
30.5 mM) increased the expression of β-catenin in the AQP1immunoprecipitates (Fig. 7C and D). Because β-catenin immunoprecip-
itates with AQP1, we analyzed the effect of AQP1 silencing on β-catenin
expression. To specifically block AQP1, again we targeted disruption of
AQP1 gene expression using 3 different species of siRNAs. In the immu-
noprecipitation experiments, treatment with AQP1 siRNAs resulted in a
substantial (N90%) reduction in AQP1 protein expression (Fig. 7B and
D). Proteins from AQP1 siRNA-transfected cells were then probed for
β-catenin abundance. β-Catenin expression in high glucose- and high
mannitol-treated cells, as well as in cells at baseline, was substantially
suppressed after transfection with siRNAs against AQP1 (Fig. 7C and D).4. Discussion
The present study reports novel findings regarding the effect of en-
vironmental conditions simulating diabetes in vitro, i.e. high glucose
and hyperosmolarity, in human iPS cells. Here we demonstrate that
concentrations of glucose up to 30.5 mM, attainable under hyperglyce-
mic conditions, induce F-actin and cytoskeleton remodeling in human
iPS cells through an AQP1-dependent hyperosmolar mechanism and,
through this mechanism, promote cell migration. These effects depend
on the hyperosmolar component of hyperglycemia rather than on
2274 R. Madonna et al. / Biochimica et Biophysica Acta 1842 (2014) 2266–2275hyperglycemia per se, as they are mimicked by the exposure of cells to
the metabolically inactive monosaccharide mannitol.
Currently available knowledge relates to the effects of high glucose
on stemandprogenitor cells [18,36], and there are no studies examining
the effects of this harmful environmental condition and the resultant
hyperosmolarity on iPS cell fate, proliferation and migration. At the
same time, there is little knowledge of the underlying mechanisms by
which biophysical (in this case hyperosmolarity) or biochemical signals
(i.e., high glucose concentrations, simulating hyperglycemia, indepen-
dent of hyperosmolarity) are transduced in changing the characteristics
and responses of iPS cells. We here demonstrate for the first time that
iPS cells are osmotically sensitive because capable of sensing and
responding to hyperosmolarity, firstly by changing size and water per-
meability, secondly by forming osmopodia and tenupodia-like struc-
tures, and finally by expressing protein targets of hyperosmolarity,
such as AQP1. Osmopodia and tenupodia in iPS cells may play a role in
migration, long distance cell–cell interaction, or even controlling cell
death processes. Immunofluorescence images of iPS cells revealed that
actin is present in these structures. Further investigation is required to
determine their physiological function.
From a molecular biology perspective, cellular responses to hyper-
osmolarity are compensatory molecular adaptations that allow the re-
establishing of homeostasis [37]. AQP1 is a water channel protein
expressed widely in vascular endothelia and fibroblasts, where it in-
creases cell membrane water permeability and migration [33,37]. AQP1
protein is expressed strongly in human and animal models of highly pro-
liferating microvessels, such as malignant brain tumors [38] and the cho-
rioallantoic membrane of the chick embryo [39]. In iPS cells, AQP1 is an
upstream mediator of hyperosmolarity, and may represent a form of
memory that these cells retain from the fibroblasts from which they
originate.
We show here that knock-down of AQP1 prevents the F-actin re-
organization and iPS cell migration induced by hyperosmolarity. In non-
silenced iPS cells, actinwasmostly expressed as polymeric (F) actin, locat-
ed in the cytoskeleton, and cells were able to migrate and organize a
pseudo-vascular network in the Matrigel model of in vitro angiogenesis
used by us. In contrast, iPS cells treated with siRNA against AQP1
expressedmostly monomeric (G) actin in the cytosol and lose the capac-
ity to organize such a network of filaments. Thus, water entry in response
to hyperosmolaritymay create local osmotic gradients driving actin poly-
merization and cell movement. This is consistent with previous findings
in other cell types, such as peritoneal mesothelial and ascitic cells [20,
40], humanmelanoma cells [41], leukocytes andmicroglia during autoim-
mune neuro-inflammation [42,43], corneal keratinocytes [44] and retinal
cells in diabetes [45]. Thus, froma functional point of view, AQP1-silenced
iPS cells decrease their capacity to migrate.
Another important finding of our work is the demonstration that
AQP1 interacts with β-catenin, and this interaction is further enhanced
in response to hyperosmolarity. In the canonical Wnt1/β-catenin path-
way, Wnt1 ligand determines nuclear translocation of β-catenin,
resulting in the regulation of gene transcription involved in cell prolifer-
ation and differentiation [46]. Recently it has been shown thatWnt1/β-
catenin signaling enhances the induction of iPS cells at early stages of
reprogramming [47]. After translocation in the nuclei, β-catenin inter-
actswith the reprogramming factors KLF4, OCT4, ANDSOX2, further en-
hancing the expression of pluripotency genes [47]. In the non-canonical
Wnt1 pathway, which is mediated by the intracellular accumulation of
calcium ions, Wnt1 ligand determines the nuclear translocation of tran-
scription factor Nuclear Factor of Activated T-cells (NFAT), resulting in a
suppression of β-catenin-dependent transcription, and activation of the
small GTPase Cdc42, involved in the remodeling of the actin cytoskele-
ton, as well as the regulation of cell shape and cell migration [48–50].
Canonical and non-canonicalWnt1 pathways seem to have opposite ef-
fects on iPS cells and stem cells, since the activation of the formerwould
lead to induction of reprogramming [47], while activation of the latter
would enhance changes in cell shape, adhesion and migration [51].We have previously observed (data not shown) that in endothelial
cells and iPS cells hyperosmolarity increases the expression of NFAT
and its nuclear translocation, suggesting an activation of the non-
canonical Wnt1 pathway in cells exposed to hyperosmolarity.
Our data, showing interaction between AQP1 and β-catenin, would
indicate that the cellular redistribution of β-catenin from the nuclei to
the cytoplasma is a consequence of hyperosmolarity, with a reduction
of the proportion of β-catenin free to translocate into the nuclei. There-
fore the interaction between AQP1 and β-catenin is probably a second-
ary effect, rather than the direct consequence of osmolarity changes. On
the contrary, activation of the non-canonical Wnt signaling pathway
would be the primary effect of hyperosmolarity, and may represent
the putative intracellular mechanism and the main downstream medi-
ator of hyperosmolarity effects on iPS cell adhesion and migration. The
effects of hyperosmolarity on canonical as well as non-canonical Wnt
pathways need however to be further characterized.
Taken together, these data show that AQP1 is a critical component
for the assembly of a plasma membrane-associated multiprotein com-
plex, ofwhichβ-catenin is an important component; and that AQP1me-
diates the stimulatory effect of hyperosmolarity on the cytoskeletal
reorganization and motility of iPS cells. Interestingly, high glucose, but
not highmannitol, which is devoid of glucosemetabolic effect, positive-
ly affected gene expression of pluripotency markers in iPS cells. This
finding is supported by previous literature reporting an increase in the
reprogrammingefficiencyof iPS cells under high-glucose conditions [14,
52,53] (reviewed in [18]). It has indeed been shown that somatic
reprogramming and pluripotency are characterized by a transition
from oxidative metabolism to anaerobic glycolysis [14]. A high concen-
tration of glucose in the culture medium stimulates the glycolytic flux,
which guarantees the production of sufficient amounts of ATP to meet
the metabolic requirements of proliferating cells [54].
The generation of iPS cells frompatients or healthydonors offers a dis-
ease model in which the patterns of growth, apoptosis and differentia-
tion, as well as physiological responses to environmental factors such as
elevated glucose concentrations and the resultant hyperosmolarity
(both common in diabetes) can be analyzed. Although we acknowledge
a limitation in our studies in not having a direct in vivo transferability, be-
cause we did not use fibroblasts derived from diabetic patients, the deri-
vation of iPS cells from commercially available human fibroblasts has
allowed us to analyze, in a selective manner, the effect of two main
players—hyperglycemia andhyperosmolarity— in the diabeticmicroen-
vironment. Our studies therefore demonstrate how iPS cellsmay serve as
in vitro disease model useful for the selective assessment of the cellular
response of stem cells to environmental factors that can play a role in
pathopysiological conditions, such as overt diabetes. Understanding the
molecular and cellular responses of iPS cells in normal and disease condi-
tionswill help in generating autologous human iPS cell lines fromhealthy
donors or diabetic patients for future therapeutic developments.Authors' contributions
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